Filing Details

Accession Number:
0000886163-11-000025
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2011-03-03 13:59:15
Reporting Period:
2011-02-24
Filing Date:
2011-03-03
Accepted Time:
2011-03-03 13:59:15
Original Submission Date:
2011-02-28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
886163 Ligand Pharmaceuticals Inc LGND Pharmaceutical Preparations (2834) 770160744
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1223000 W John Kozarich 11085 North Torrey Pines Road, Suite 300
La Jolla CA 92037
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-02-24 1,000 $9.96 14,726 No 4 P Direct
Common Stock Acquisiton 2011-02-24 2,000 $10.00 16,726 No 4 P Direct
Common Stock Acquisiton 2011-02-24 211 $9.94 16,937 No 4 P Direct
Common Stock Acquisiton 2011-02-25 1,789 $9.99 18,726 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. This amendment is being made to correct the transaction code to reflect an open market purchase.